ALDX: Aldeyra Therapeutics, Inc. Stock

by  •  • Comments Off on ALDX: Aldeyra Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 250.13
Enterprise Value ($M) 212.85
Book Value ($M) 113.42
Book Value / Share 1.91
Price / Book 2.21
NCAV ($M) 112.96
NCAV / Share 1.90
Price / NCAV 2.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 6.50
Current Ratio 6.50

Balance Sheet (mrq) ($M)
Current Assets 140.85
Assets 141.30
Liabilities 27.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.79
Net Income -37.54
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.33
Cash from Investing 30.00
Cash from Financing -1.27

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perceptive Advisors Llc 14.60 0.00
02-13 13G Vanguard Group Inc 6.68
01-29 13G BlackRock Inc. 5.80 251.89
10-04 13G Knoll Capital Management, LLC 6.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-07 10-K Form 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 65,809 297,771 22.10
2024-05-02 70,000 94,168 74.34
2024-05-01 98,334 121,874 80.68
2024-04-30 29,378 92,062 31.91

(click for more detail)

Similar Companies
AKAN – Akanda Corp. AKBA – Akebia Therapeutics, Inc.
ALBT – Avalon GloboCare Corp. ALGS – Aligos Therapeutics, Inc.
ALRN – Aileron Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io